U.S. flag

An official website of the United States government

NM_002778.4(PSAP):c.128G>A (p.Gly43Glu) AND Metachromatic leukodystrophy

Germline classification:
Benign (1 submission)
Last evaluated:
Jan 16, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001829458.2

Allele description [Variation Report for NM_002778.4(PSAP):c.128G>A (p.Gly43Glu)]

NM_002778.4(PSAP):c.128G>A (p.Gly43Glu)

Gene:
PSAP:prosaposin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q22.1
Genomic location:
Preferred name:
NM_002778.4(PSAP):c.128G>A (p.Gly43Glu)
HGVS:
  • NC_000010.11:g.71834418C>T
  • NG_009301.1:g.21908G>A
  • NM_001042465.3:c.128G>A
  • NM_001042466.3:c.128G>A
  • NM_002778.4:c.128G>AMANE SELECT
  • NP_001035930.1:p.Gly43Glu
  • NP_001035931.1:p.Gly43Glu
  • NP_002769.1:p.Gly43Glu
  • NC_000010.10:g.73594175C>T
  • NM_002778.2:c.128G>A
  • NM_002778.3:c.128G>A
Protein change:
G43E
Links:
dbSNP: rs558427025
NCBI 1000 Genomes Browser:
rs558427025
Molecular consequence:
  • NM_001042465.3:c.128G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042466.3:c.128G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002778.4:c.128G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Metachromatic leukodystrophy (MLD)
Synonyms:
Metachromatic leukoencephalopathy; Sulfatide lipidosis; Cerebral sclerosis diffuse metachromatic form; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0018868; MedGen: C0023522; Orphanet: 512; OMIM: 250100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002087097Natera, Inc.
no assertion criteria provided
Benign
(Jan 16, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002087097.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 4, 2024